Diseases
Researchers have developed a novel, cost-effective experimental paradigm using Drosophila wing discs to study Alzheimer's disease and screen for disease-modifying therapies. This innovative approach yields results in days, while offering the advantages of a genetically tractable in vivo system. The study demonstrates the potential of this paradigm in
Diseases
A recent study published in Molecular Neurobiology has shed light on the potential role of sex in the development of Alzheimer's disease (AD). The research, conducted by a team of scientists from Federal University Rio Grande do Sul, explored the effects of the unfolded protein response (UPR) on
Diseases
Merry Life Biomedical Company has announced the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). The multicenter trial will enroll 210 patients with mild cognitive impairment (MCI) or mild dementia across the United States, Sweden,
Diseases
The Alzheimer's disease pipeline is rapidly evolving, with 200+ key pharma companies actively working on therapeutic candidates for the treatment of Alzheimer's disease. A recent report by DelveInsight highlights the comprehensive pipeline landscape, including 220+ pipeline drugs in various stages of development. The pipeline report provides
Diseases
Research has shown that two common kitchen herbs, rosemary and sage, may offer potential protections against dementia and boost memory. The antioxidants and anti-inflammatory agents found in these herbs, particularly carnosic acid, may help reduce the risk of Alzheimer's disease. A recent study published in the Antioxidants journal
Diseases
Research has shed light on the potential connection between traumatic brain injuries (TBIs) and an increased risk of Alzheimer's disease (AD) in Vietnam War veterans. The study, conducted by Ohio State University, examined the synergistic effects of TBI and genetic risk for AD on beta-amyloid (Ab) levels in
Diseases
Researchers at the University of Rochester have made a significant breakthrough in personalized medicine by developing a new diagnostic tool for Alzheimer's disease. According to a new study, the auditory brainstem response (ABR) can be used as a rapid, low-cost, noninvasive biomarker to assist in the diagnostic testing
Diseases
Researchers from Sichuan Normal University have evaluated the physicochemical properties, antioxidant activity, and anti-Alzheimer's disease (AD) effects of Cremastra appendiculata polysaccharides (CAPs) in vitro and in Caenorhabditis elegans (C. elegans) AD models. The study demonstrates that CAP has potent antioxidant and anti-AD effects, alleviating amyloid-beta (A beta) and
Diseases
Researchers at Baqai Medical University have recently published a study exploring the transformative potential of immunotherapies in the treatment of Alzheimer's disease. According to the study, recent advances in immunotherapy have yielded monoclonal antibodies with unprecedented precision in targeting amyloid-beta aggregates, offering hope for altering the disease trajectory.
Diseases
Researchers have made significant strides in understanding the genetic underpinnings of Alzheimer's disease (AD), with a recent study shedding light on the role of the apolipoprotein E gene (APOE) in disease risk. The APOE gene's ?4 allele has long been associated with increased risk of AD,
Associations
A unique fundraiser was held by the April Burger of the Month winner, Cilantro and Chive, in support of the Alzheimer's Society of Alberta and the Northwest Territories (NWT). The event aimed to raise funds for research and better treatment options for Alzheimer's disease, a chronic
Associations
The residents and staff at Chatsworth Lodge Care Home in Chesterfield, Derbyshire, came together to organize a fun-filled walk from the care home to Queens Park and back as part of Dementia Action Week. The event was led by the Alzheimer's Society and aimed at raising awareness, promoting
